These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 25979421)
21. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta. Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942 [TBL] [Abstract][Full Text] [Related]
22. Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells. Hall BM; Verma ND; Tran GT; Hodgkinson SJ Curr Opin Immunol; 2011 Oct; 23(5):641-7. PubMed ID: 21840184 [TBL] [Abstract][Full Text] [Related]
23. A Context-Dependent Role for αv Integrins in Regulatory T Cell Accumulation at Sites of Inflammation. Mair I; Zandee SEJ; Toor IS; Saul L; McPherson RC; Leech MD; Smyth DJ; O'Connor RA; Henderson NC; Anderton SM Front Immunol; 2018; 9():264. PubMed ID: 29535709 [TBL] [Abstract][Full Text] [Related]
24. Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity. Presser K; Schwinge D; Wegmann M; Huber S; Schmitt S; Quaas A; Maxeiner JH; Finotto S; Lohse AW; Blessing M; Schramm C J Immunol; 2008 Dec; 181(11):7751-8. PubMed ID: 19017964 [TBL] [Abstract][Full Text] [Related]
25. Impaired expansion of regulatory T cells in a neonatal thymectomy-induced autoimmune mouse model. Yamada A; Ushio A; Arakaki R; Tsunematsu T; Kudo Y; Hayashi Y; Ishimaru N Am J Pathol; 2015 Nov; 185(11):2886-97. PubMed ID: 26343329 [TBL] [Abstract][Full Text] [Related]
26. Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis. Lee CR; Kwak Y; Yang T; Han JH; Park SH; Ye MB; Lee W; Sim KY; Kang JA; Kim YC; Mazmanian SK; Park SG Cell Rep; 2016 Dec; 17(12):3219-3232. PubMed ID: 28009291 [TBL] [Abstract][Full Text] [Related]
27. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204 [TBL] [Abstract][Full Text] [Related]
28. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells. Horie S; Sugita S; Futagami Y; Yamada Y; Mochizuki M Clin Immunol; 2010 Jul; 136(1):83-95. PubMed ID: 20350837 [TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1-dependent immune regulation by transforming growth factor-β2-exposed antigen-presenting cells. Mir FA; Contreras-Ruiz L; Masli S Immunology; 2015 Dec; 146(4):547-56. PubMed ID: 26458493 [TBL] [Abstract][Full Text] [Related]
30. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115 [TBL] [Abstract][Full Text] [Related]
31. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Kosiewicz MM; Alard P; Liang S; Clark SL Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction. Bellinghausen I; König B; Böttcher I; Knop J; Saloga J Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678 [TBL] [Abstract][Full Text] [Related]
35. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity. Luo CT; Liao W; Dadi S; Toure A; Li MO Nature; 2016 Jan; 529(7587):532-6. PubMed ID: 26789248 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes. Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157 [TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Izcue A; Coombes JL; Powrie F Immunol Rev; 2006 Aug; 212():256-71. PubMed ID: 16903919 [TBL] [Abstract][Full Text] [Related]
38. Litomosoides sigmodontis induces TGF-β receptor responsive, IL-10-producing T cells that suppress bystander T-cell proliferation in mice. Hartmann W; Schramm C; Breloer M Eur J Immunol; 2015 Sep; 45(9):2568-81. PubMed ID: 26138667 [TBL] [Abstract][Full Text] [Related]
39. Mesangial cell integrin αvβ8 provides glomerular endothelial cell cytoprotection by sequestering TGF-β and regulating PECAM-1. Khan S; Lakhe-Reddy S; McCarty JH; Sorenson CM; Sheibani N; Reichardt LF; Kim JH; Wang B; Sedor JR; Schelling JR Am J Pathol; 2011 Feb; 178(2):609-20. PubMed ID: 21281793 [TBL] [Abstract][Full Text] [Related]